At the 2023 World Congress on Gastrointestinal Cancers, Michael Pishvaian, MD, PhD, shared data from the first interim analysis of a phase 3 study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Intra-Arterial Gemcitabine Showed Promise for Locally Advanced Pancreatic Cancer
